PhD studentship

PhD studentship at Cardiff University / Cardiff School of Biosciences on CD200 immune checkpoint targeting in prostate cancer . The project investigates how CD200 regulates prostate cancer stem cell function, tumour immune evasion, and response to therapy, with a focus on a novel small-molecule CD200 inhibitor (p1019.7) and combination treatment with pembrolizumab. Research themes include prostate cancer , cancer stem cells , immunology , genomics , bioinformatics , molecular biology , cell biol...

EMBO Postdoctoral Fellowship 2027 is a competitive, fully funded postdoctoral opportunity from the European Molecular Biology Organization for early-career researchers in biomedical science and molecular biology . The fellowship supports mobile research projects across Europe and globally, making it a strong fit for candidates seeking international postdoctoral training in life sciences, biomedical research, and related areas. Funding is described as a postdoctoral scale stipend that varies by h...

European Molecular Biology Organization (EMBO) Postdoctoral Fellowships are listed at Harvard University in the United States , with the work location shown as Cambridge, Massachusetts . This opportunity is for postdoctoral research and is intended to support research visits to laboratories throughout Europe and the world. The fellowship emphasizes international exchange and mobility , and applications must involve a change of country . Applicants cannot apply to go to the country where the PhD ...

Department of Pathology, University of Cambridge is sharing a fully funded PhD studentship in the lab of Professor Suzanne Turner on the impact of environmental plastic pollution on human health, with a focus on micro- and nanoplastics (M/NP) . The project will investigate how chemicals and particles associated with plastics interact with the immune system , including possible roles in chronic inflammation and immune-related diseases such as lymphoma . Research methods include in vitro and in vi...

PhD studentship at the University of Cambridge on unmasking mechanisms of resistance to KRAS inhibition across pancreatic cancer genetic profiles . This project is hosted in Dr Giulia Biffi’s research group and focuses on pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer with major unmet clinical need. The research addresses an important clinical question: why do PDAC tumours rapidly develop resistance to KRAS inhibitors, even as these drugs represent a new therapeutic opportun...